Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
2
4
0
0
Pear Therapeutics, Inc.
Share · US7047231052 · PEAR (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Pear Therapeutics, Inc.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 38,87 %
Shares Float 54,43 M
Shares Outstanding 140,03 M
Company Profile for Pear Therapeutics, Inc. Share
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
Company Data
Name Pear Therapeutics, Inc.
Company Pear Therapeutics, Inc.
Symbol PEAR
Website
https://peartherapeutics.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US7047231052
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Christopher D. T. Guiffre MBA
Country United States of America
Currency USD
Employees 0,2 T
Address 200 State Street, 02109 Boston
IPO Date 2021-03-31
ID Changes
| Date | From | To |
|---|---|---|
| 06.12.2021 | THMA | PEAR |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | PEAR |
More Shares
Investors who hold Pear Therapeutics, Inc. also have the following shares in their portfolio:
